Medico Reach

AUGUST 12, 2022

billion In operation since: 2008 Biosplice Therapeutics aims to restore health by harnessing alternative splicing and offering therapy. billion In operation since: 2008 Caris Life Sciences aims to revolutionize cancer care. Website: www.tempus.com. Osam Kibar. Company: Biosplice Therapeutics Age: 48 years (1974 born) Net worth : $2.9

Healthcare 98

Healthcare Healthcare Healthcare Provider Engineering 98

European Pharmaceutical Review

SEPTEMBER 13, 2023

Opened in 2008, the facility was MSD’s first vaccines operation outside of the US. In total, both projects represent an investment of over €1 billion” MSD Carlow runs as filling site for the launch and commercial supply of vaccines , biologics, and small molecule drug products.

Manufacturing 98

Manufacturing Medicine Engineering Networking 98

Pharmaceutical Technology

OCTOBER 10, 2024

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Food 52

Food 52

PharmaTech

NOVEMBER 1, 2024

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

52

52

pharmaphorum

JULY 21, 2022

” There will be no dramatic change in direction at Roche under the new CEO, according to Schwan, who was named CEO way back in 2008 and has been at the company throughout his entire career, joining the company in the early 1990s.

Sales 119

Sales Pharma Competition Management 119

World of DTC Marketing

JANUARY 12, 2021

While these numbers may pale in comparison with the 18-29 (86%) and 30-49 (61%) groups, it should be noted that as of November 2008 (a short time ago) only 16% of the 50-64-year-old group and 4% of the 65+ group were using Facebook. This represents 31% of all seniors in the US.

Patients 155

Patients Media Marketing Prescription 155

European Pharmaceutical Review

AUGUST 15, 2022

Instead, DTP3 coverage was set back to its lowest level since 2008 which, along with declines in coverage for other basic vaccines, pushed the world off-track to meet global goals, including the immunisation indicator for the Sustainable Development Goals. million children missed their first measles dose in 2021, 5.3 A further 14.7

Manufacturing 98

Manufacturing Pharma Leads Pharmaceutical 98

Legacy MEDSearch

MAY 3, 2023

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012).

Recruitment 98

Recruitment Medical Management Media 98

European Pharmaceutical Review

APRIL 3, 2023

In 2008, the ALK gene was found to hold a key role in the disease. Lorlatinib – could it change standard treatment for neouroblastoma? “This is in a population known to have inferior survival with standard-of-care, high-risk therapy,” Goldsmith explained.

Food and Drug Administration 97

Food and Drug Administration Patients Medicine Food 97

European Pharmaceutical Review

APRIL 19, 2023

In 2008, the importance of rigorous monitoring and quality control (QC) of pharmaceutical heparin was highlighted, when existing regulatory procedures failed to identify a life-threatening adulteration of the substance with oversulfated chondroitin sulfate (OSCS), an unnatural, chemically modified GAG polysaccharide.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Marketing 98

pharmaphorum

JANUARY 19, 2023

When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.” Since 2008, the budget for NHS has grown 1% and the market 4%. Highly unlikely.” GIRFT and competition He went on: “Improvement needs competition – everything else is a proxy; it doesn’t work well. There’s no silver bullet,” Lord Prior said.

Pharma 96

Pharma Competition Healthcare Healthcare 96

World of DTC Marketing

JUNE 4, 2021

Obesity-related medical care costs in the United States, in 2008 dollars, were an estimated $147 billion. Additional contributing factors include the food and physical activity environment, education and skills, and food marketing and promotion. Annual nationwide productivity costs of obesity-related absenteeism range between $3.38

Food 207

Food Insurance Leads Medical 207

Clarivate

SEPTEMBER 25, 2024

3] Figure 1: The Development of Targeted Treatments for Syphilis Source: Valent P et al, 2016;3 Strebhardt K et al, 2008. [4] 2008 2008/06/01;8(6):473-80. [5] 2008) Gleevec: the Breakthrough in Cancer Treatment. 4] How realistic is the ‘magic bullet’ concept in pharmaceutical development? Journal of Innate Immunity.

Medicine 59

Medicine Side effects Patients Pharmaceutical 59

European Pharmaceutical Review

FEBRUARY 2, 2023

The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe” The closure of API manufacturing plants in Europe started in earnest 15 years ago.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111

Impetus Digital

APRIL 6, 2023

Yeadon sits down with host Greg Muzzillo from the Million Dollar Podcast to share how she took a leap of faith by founding a virtual-based company in 2008, and has since transformed pharmaceuticals meetings, events, and programs across the globe.

Pharmaceutical 52

Pharmaceutical Professional Services Healthcare Provider Consulting 52

Pharmacy Times

DECEMBER 8, 2022

Study finds textured breast implants do not increase the risk of anaplastic large-cell lymphoma, which has grown in incidence since 2008.

29

29

pharmaphorum

OCTOBER 12, 2022

Albani and his cofounder Berent Prakken have been working in this field since 2008, applying translational thinking to the many seismic shifts that have happened in that time. The objective is to transform what is a whole series of tug-of-wars into rowing together.”. Translational medicine and digital health.

Medicine 111

Medicine Training Education Healthcare 111

pharmaphorum

JANUARY 4, 2023

The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. It is sold as Rapiscan in Europe by GE Healthcare.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

European Pharmaceutical Review

DECEMBER 13, 2022

24 June 2008. FDA Guidance for Industry Testing of Glycerin for Diethylene Glycol. USP-NF Propylene Glycol Monograph: USP43-NF38, 2010, 3753. Scientific Committee on Consumer Products. SCCP OPINION ON Diethylene glycol. Good distribution practices for bulk pharmaceutical excipients. Thakur DS, Thikkavarapu PR.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Food 105

PM360

FEBRUARY 12, 2024

This February we celebrate the 16th annual Rare Disease Day , established in 2008, to raise awareness of the more than 7,000 identified rare diseases worldwide. Rare Disease Day is observed annually on the “rarest” day of the year, February 28th or 29th depending on leap years.

Food and Drug Administration 105

Food and Drug Administration Patients Medical Networking 105

Clarivate

AUGUST 17, 2022

Dr. Grace Lomax, who co-founded Patient Connect with her sister in 2008, came up with the idea for the solution when she started asking patients in her clinic what information they wanted when and how. Neville Hobson [Host]: You founded Patient Connect together with your sister Zoe Barker in 2008.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

pharmaphorum

SEPTEMBER 21, 2022

billion buyout of Millennium Pharma way back in 2008 – but those were dashed in 2015 when the drug failed to move the needle in a trial involving patients with peripheral T-cell lymphoma (PTCL). Takeda is also in line for just over $287 million in potential milestone payments, plus royalties on net sales if it reaches the market.

Patients 64

Patients Sales Pharma Marketing 64

Salesforce

MARCH 3, 2022

After the accident in 2008, Schultz was anxious to get back into sports, but struggled to find prosthetics to support extreme movement. Turning data into insights: how activity data replaces trial and error. But I’m a garage guy,” he said. “I

Specialization 98

Specialization Competition Medical 98

pharmaphorum

DECEMBER 1, 2022

According to Diabetes UK, the prevalence of T2D is on the rise in Scotland – with a 40% increase in diagnosed cases recorded between 2008-2018 – and now, more than 300,000 people are living with T2D in Scotland, including those not yet diagnosed.

Consulting 59

Consulting Safety Patients Medicine 59

Legacy MEDSearch

APRIL 11, 2023

About Moximed Moximed was founded in 2008 and is dedicated to helping people with mild to moderate osteoarthritis preserve their knee joints while living healthy, active lives. For these patients, total knee replacement is a reluctant option, as it is an end-stage treatment for end-stage disease.

Marketing 96

Marketing FDA Food and Drug Administration Recruitment 96

European Pharmaceutical Review

JUNE 12, 2024

2017; 55(7):1998-2008. Peng Z, Jin D, Kim HB, et al. Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing. J Clin Microbiol. About the author Dr Olaia Aurtenetxe is the Head of Clinical Research at Mikrobiomik.

Safety 111

Safety Patients Side effects Healthcare 111

pharmaphorum

JANUARY 3, 2023

In an illustrious career, he also served as president of the Royal Society of Medicine (RSM) from 2012 to 2014, as well as chairman of the Committee on Safety of Medicines (1992-1998), chairman of the Advisory Council on the Misuse of Drugs (1998-2008), and chairman of UK Biobank (2012-2019), and was also appointed honorary professor at the London (..)

Medicine 52

Medicine Side effects Safety Healthcare 52

pharmaphorum

NOVEMBER 1, 2022

In 2008, the startup launched its first API to make and receive phone calls entirely in the cloud. Widespread adoption of these protocols allows every stakeholder in the environment to expect a well-defined behaviour when interfacing digitally with one another. The power of the open-protocol approach has been realised across many industries.

Patients 98

Patients Electronics Healthcare Healthcare 98

pharmaphorum

SEPTEMBER 26, 2022

It was first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas top products. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

Clarivate

OCTOBER 4, 2023

The Solution: Unified IP lifecycle management In 2008, Philips turned to ipan, now part of Clarivate , to handle renewals. Next to that Philips is also quite active in registering new design rights and trademarks. All the formalities in relation to filing and prosecution are handled by the IP Support group.” ” de Haan explains.

Management 59

Management Networking Leads Patients 59

pharmaphorum

JANUARY 9, 2023

Albireo – which spun out of AstraZeneca in 2008 and was formally based in Sweden – has said it thinks Bylvay has the potential to become a $1 billion-plus product if approved for all three of its target indications. FDA approval in this indication would unlock the additional $10 CVR payment, providing it takes place before the end of 2027.

Transportation 52

Transportation Sales Leads FDA 52

pharmaphorum

JULY 15, 2022

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

Prescription 52

Prescription Marketing Doctors Government 52

The Brooks Group

OCTOBER 14, 2019

Companies who proactively recognized the threat ahead of the 2008 recession achieved six percentage points better Total Shareholder Return in the downturn than companies that did not address the challenge early. Now is the time to begin “building a moat” around your organization and safeguarding from uncertainty.

Competition 60

Competition Sales Sales process Consulting 60

Nixon Gwilt Law

FEBRUARY 27, 2023

How the New DEA Proposal for Tele-Prescribing Differs from the PHE Waivers and Flexibilities Outside of the Public Health Emergency (PHE), which is set to expire on May 11, 2023, current DEA regulations based on the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Ryan Haight Act”) prohibit tele-prescribing controlled substances for (..)

Prescription 105

Prescription Medical Patients Specialization 105

Legacy MEDSearch

SEPTEMBER 28, 2023

About 4WEB Medical 4WEB Medical, founded in 2008 in Dallas, TX, is an orthopedic implant company. We are excited to launch several new cervical products before the end of the year and look forward to capitalizing on this success with significant growth in 2024,” said Geoff Bigos, Vice President of 4WEB Medical’s Spine Division.

Medical 52

Medical Marketing Recruitment Management 52

Clarivate

JULY 27, 2023

GPON standards were finalized by ITU-T in 2003 and their mass deployment started around 2008. PON provides last mile connectivity typically called FTTx, depending on where the optical fiber terminates. Later, 10Gigabit capable PON standards emerged between 2010 and 2017 addressing increasing bandwidth needs.

Networking 52

Networking Distribution Media Management 52

European Pharmaceutical Review

FEBRUARY 1, 2024

Michael was the cofounding Chief Medical Officer of Omthera Pharmaceuticals in 2008. Before joining NewAmsterdam Pharma, Michael was founder and Chief Medical Officer of Corvidia Therapeutics, which was sold to Novo Nordisk in July 2020.

Pharma 97

Pharma Patients Pharmaceutical Leads 97